General Archive
-
News releasesLifeArc launches first study of Our Future Health data using in-house data science capabilities
Our Future Health holds rich, in-depth data on its consented participants. For future research and the development of new tests…
-
Our Future Health: Accelerating health research using clinical data
Our Future Health: Accelerating health research using clinical data We have partnered with Our Future Health (OFH), the world’s largest…
-
USAMRIID: A transatlantic collaboration to develop a treatment for Crimean-Congo hemorrhagic fever
USAMRIID: A transatlantic collaboration to develop a treatment for Crimean-Congo hemorrhagic fever We have joined forces with the U.S. Army…
-
King’s College London EPSRC Centre for Doctoral Training in Data-Driven Health: Seminar Series
About the event The EPSRC Centre for Doctoral Training in Data-Driven Health (DRIVE-Health) trains the next generation of health data scientists,…
-
News releasesLifeArc and Cleveland Clinic join forces to develop new monoclonal antibody therapeutics for patients with high unmet medical needs
LifeArc and Cleveland Clinic, a nonprofit, multispecialty academic medical centre, have signed a new 10-year Master Services Agreement (MSA) for…
-
Funding call for innovations for exceptionally low-cost monoclonal antibody (mAb) manufacturing
Funding: Call for innovations for exceptionally low-cost monoclonal antibody (mAb) manufacturing In partnership with The Gates Foundation, we are requesting…
-
LifeArc antibody showcase at Babraham Research Campus
About the showcase We are hosting a roadshow to showcase the capabilities of our newly launched antibody discovery platform, B-SMART™,…
-
Protein and Antibody Engineering Europe Summit
About the event The Protein and Antibody Engineering Europe Summit is the largest protein and antibody engineering event in Europe,…
-
Pharma Integrates
About the event Pharma Integrates is a premier event uniting leaders across the pharmaceutical pipeline to address their needs, exchange…
-
News releasesTwo major UK decisions announced on use of Alzheimer’s drug, lecanemab
Today, two major decisions have been made on lecanemab (Leqembi®) – the Alzheimer’s drug that we helped humanise, which slows the…
-
ArticlesLifeArc contributes to organic chemistry breakthrough
The findings reveal that seemingly impossible chemical reactions can be driven through a phenomenon called quantum tunnelling.
-
ArticlesStudy reveals potential new way to treat colorectal cancer
Scientists discovered an IL-17B receptor antibody could be used to treat colorectal cancer.